H1B Report
Side-by-side comparison

Microsoft Corporation vs Takeda Pharmaceuticals USA, Inc.

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
Microsoft Corporation
WARank #6FEIN 91-1144442
Entity B
Takeda Pharmaceuticals USA, Inc.
MARank #FEIN 13-4013710

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricMicrosoft CorporationTakeda Pharmaceuticals USA, Inc.
Total filings70,316204
Certified %94.15%81.86%
Denied %0.12%1.47%
Withdrawn %0.71%1.96%
Cert-withdrawn %5.02%14.71%
Rank#6
Active yearsFY2010–FY2026FY2010–FY2026
Worksite stateWAMA

Outcomes — Microsoft Corporation

DOL case-status mix.

Outcome breakdown: Certified 94.2%, Cert-withdrawn 5.0%, Withdrawn 0.7%, Denied 0.1%
Outcome breakdown
OutcomeShare
Certified94.2%
Cert-withdrawn5.0%
Withdrawn0.7%
Denied0.1%
Certified94.2%
Cert-withdrawn5.0%
Withdrawn0.7%
Denied0.1%

Outcomes — Takeda Pharmaceuticals USA, Inc.

DOL case-status mix.

Outcome breakdown: Certified 81.9%, Cert-withdrawn 14.7%, Withdrawn 2.0%, Denied 1.5%
Outcome breakdown
OutcomeShare
Certified81.9%
Cert-withdrawn14.7%
Withdrawn2.0%
Denied1.5%
Certified81.9%
Cert-withdrawn14.7%
Withdrawn2.0%
Denied1.5%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

Microsoft Corporation
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20104,390
FY20114,184
FY20123,943
FY20133,813
FY20143,637
FY20154,452
FY20164,888
FY20174,806
FY20185,438
FY20195,916
FY202051
FY2021110
FY2022150
FY20232,791
FY20249,492
FY20259,362
FY20262,893
Takeda Pharmaceuticals USA, Inc.
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20102
FY20110
FY20122
FY201310
FY20141
FY20155
FY201610
FY20175
FY20188
FY20196
FY20205
FY202126
FY202210
FY202319
FY202442
FY202547
FY20266

Top 5 occupations — Microsoft Corporation

Top 5 occupations — Takeda Pharmaceuticals USA, Inc.

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.